Format
Items per page
Sort by

Send to:

Choose Destination

Results: 17

1.

Management of malignant pleural mesothelioma-The European experience.

Opitz I.

J Thorac Dis. 2014 May;6 Suppl 2:S238-52. doi: 10.3978/j.issn.2072-1439.2014.05.03. Review.

PMID:
24868442
[PubMed]
Free PMC Article
2.

Surgical management of malignant pleural mesothelioma: impact of surgery on survival and quality of life-relation to chemotherapy, radiotherapy, and alternative therapies.

Papaspyros S, Papaspyros S.

ISRN Surg. 2014 Feb 3;2014:817203. doi: 10.1155/2014/817203. eCollection 2014. Review.

PMID:
24624305
[PubMed]
Free PMC Article
3.

Identification of a seven glycopeptide signature for malignant pleural mesothelioma in human serum by selected reaction monitoring.

Cerciello F, Choi M, Nicastri A, Bausch-Fluck D, Ziegler A, Vitek O, Felley-Bosco E, Stahel R, Aebersold R, Wollscheid B.

Clin Proteomics. 2013 Nov 8;10(1):16. doi: 10.1186/1559-0275-10-16.

PMID:
24207061
[PubMed]
Free PMC Article
4.

Multimodality therapy for malignant pleural mesothelioma.

Weder W, Opitz I.

Ann Cardiothorac Surg. 2012 Nov;1(4):502-7. doi: 10.3978/j.issn.2225-319X.2012.11.12. No abstract available.

PMID:
23977544
[PubMed]
Free PMC Article
5.

Pleurectomy/decortication, chemotherapy, and intensity modulated radiation therapy for malignant pleural mesothelioma: rationale for multimodality therapy incorporating lung-sparing surgery.

Zauderer MG, Krug LM.

Ann Cardiothorac Surg. 2012 Nov;1(4):487-90. doi: 10.3978/j.issn.2225-319X.2012.10.08. No abstract available.

PMID:
23977541
[PubMed]
Free PMC Article
6.

Radical surgery for malignant pleural mesothelioma: have we identified the appropriate selection tools?

van Zandwijk N, Reid G, Linton A, Kao S.

Ann Cardiothorac Surg. 2012 Nov;1(4):481-6. doi: 10.3978/j.issn.2225-319X.2012.10.01. No abstract available.

PMID:
23977540
[PubMed]
Free PMC Article
7.

Do we need a revised staging system for malignant pleural mesothelioma? Analysis of the IASLC database.

Rusch VW, Giroux D.

Ann Cardiothorac Surg. 2012 Nov;1(4):438-48. doi: 10.3978/j.issn.2225-319X.2012.11.10.

PMID:
23977534
[PubMed]
Free PMC Article
8.

Systematic review of trimodality therapy for patients with malignant pleural mesothelioma.

Cao C, Tian D, Manganas C, Matthews P, Yan TD.

Ann Cardiothorac Surg. 2012 Nov;1(4):428-37. doi: 10.3978/j.issn.2225-319X.2012.11.07.

PMID:
23977533
[PubMed]
Free PMC Article
9.

Safety and efficacy of trimodality therapy in patients undergoing extrapleural pneumonectomy.

Bölükbas S.

Chin J Cancer Res. 2013 Apr;25(2):130-1. doi: 10.3978/j.issn.1000-9604.2013.02.04. No abstract available.

PMID:
23592891
[PubMed]
Free PMC Article
10.

New insights into understanding the mechanisms, pathogenesis, and management of malignant mesotheliomas.

Mossman BT, Shukla A, Heintz NH, Verschraegen CF, Thomas A, Hassan R.

Am J Pathol. 2013 Apr;182(4):1065-77. doi: 10.1016/j.ajpath.2012.12.028. Epub 2013 Feb 8. Review.

PMID:
23395095
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

A seven-year disease-free survivor of malignant pleural mesothelioma treated with hyperthermia and chemotherapy: a case report.

Okonogi N, Ebara T, Ishikawa H, Yoshida D, Ueno M, Maeno T, Suga T, Nakano T.

J Med Case Rep. 2012 Dec 28;6:427. doi: 10.1186/1752-1947-6-427.

PMID:
23272646
[PubMed]
Free PMC Article
12.

Investigational approaches for mesothelioma.

Surmont VF, van Thiel ER, Vermaelen K, van Meerbeeck JP.

Front Oncol. 2011 Aug 22;1:22. doi: 10.3389/fonc.2011.00022. eCollection 2011.

PMID:
22666659
[PubMed]
Free PMC Article
13.

First-line chemotherapy with liposomal doxorubicin plus cisplatin for patients with advanced malignant pleural mesothelioma: phase II trial.

Arrieta Ó, Medina LA, Estrada-Lobato E, Hernández-Pedro N, Villanueva-Rodríguez G, Martínez-Barrera L, Macedo EO, López-Rodríguez V, Motola-Kuba D, Corona-Cruz JF.

Br J Cancer. 2012 Mar 13;106(6):1027-32. doi: 10.1038/bjc.2012.44. Epub 2012 Feb 21.

PMID:
22353806
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Volumetric modulated arc therapy: a review of current literature and clinical use in practice.

Teoh M, Clark CH, Wood K, Whitaker S, Nisbet A.

Br J Radiol. 2011 Nov;84(1007):967-96. doi: 10.1259/bjr/22373346. Review.

PMID:
22011829
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study.

Treasure T, Lang-Lazdunski L, Waller D, Bliss JM, Tan C, Entwisle J, Snee M, O'Brien M, Thomas G, Senan S, O'Byrne K, Kilburn LS, Spicer J, Landau D, Edwards J, Coombes G, Darlison L, Peto J; MARS trialists.

Lancet Oncol. 2011 Aug;12(8):763-72. doi: 10.1016/S1470-2045(11)70149-8. Epub 2011 Jun 30.

PMID:
21723781
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

The evolution of multimodality therapy for malignant pleural mesothelioma.

Zauderer MG, Krug LM.

Curr Treat Options Oncol. 2011 Jun;12(2):163-72. doi: 10.1007/s11864-011-0146-4.

PMID:
21404104
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Comparison of CT and integrated PET-CT based radiation therapy planning in patients with malignant pleural mesothelioma.

Pehlivan B, Topkan E, Onal C, Nursal GN, Yuksel O, Dolek Y, Yavuz MN, Yavuz AA.

Radiat Oncol. 2009 Sep 16;4:35. doi: 10.1186/1748-717X-4-35.

PMID:
19758456
[PubMed - indexed for MEDLINE]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk